Weight & metabolism
This is where peptide research is strongest. Several peptides in this group are FDA-approved medicines backed by large human trials. Others are still investigational.
Foundations first
No peptide replaces these. They drive most of the results.
Peptides researched for weight & metabolism
Ranked from strongest to earliest-stage evidence.
Semaglutide
A GLP-1 receptor agonist and one of the most studied peptide medicines in the world.
FDA-approved drugDual GIP / GLP-1 receptor agonistTirzepatide
The first approved medicine that activates both the GIP and GLP-1 receptors.
FDA-approved drugGHRH analogTesamorelin
A growth-hormone-releasing hormone analog with a narrow FDA approval.
FDA-approved drugTriple GIP / GLP-1 / glucagon receptor agonistRetatrutide
An investigational "triple agonist" currently in late-stage clinical trials.
Human clinical trialsLong-acting amylin analogCagrilintide
An amylin analog being studied alone and in combination with semaglutide.
Human clinical trialsModified growth hormone fragmentAOD-9604
A fragment of growth hormone once developed as an obesity drug.
Human clinical trialsMitochondrial-derived peptideMOTS-c
A peptide encoded in mitochondrial DNA, studied for its role in metabolism.
Mostly animal researchEducational content, not medical advice. Talk to a licensed provider before starting anything.